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Abstract
Background: Vendor-independent Monte Carlo (MC) dose calculation (IDC) for patient-specific quality assurance
of multi-leaf collimator (MLC) based CyberKnife treatments is used to benchmark and validate the commercial
MC dose calculation engine for MLC based treatments built into the CyberKnife treatment planning system
(Precision MC).
Methods: The benchmark included dose profiles in water in 15 mm depth and depth dose curves of rectangular
MLC shaped fields ranging from 7.6 mm × 7.7 mm to 115.0 mm × 100.1 mm, which were compared between IDC,
Precision MC and measurements in terms of dose difference and distance to agreement. Dose distributions of
three phantom cases and seven clinical lung cases were calculated using both IDC and Precision MC. The lung
PTVs ranged from 14 cm3 to 93 cm3. Quantitative comparison of these dose distributions was performed using
dose-volume parameters and 3D gamma analysis with 2% global dose difference and 1 mm distance criteria and
a global 10% dose threshold. Time to calculate dose distributions was recorded and efficiency was assessed.
Results: Absolute dose profiles in 15 mm depth in water showed agreement between Precision MC and IDC within
3.1% or 1 mm. Depth dose curves agreed within 2.3% / 1 mm. For the phantom and clinical lung cases, mean PTV
doses differed from − 1.0 to + 2.3% between IDC and Precision MC and gamma passing rates were > =98.1% for all
multiple beam treatment plans. For the lung cases, lung V20 agreed within ±1.5%. Calculation times ranged from
2.2 min (for 39 cm3 PTV at 1.0 × 1.0 × 2.5 mm3 native CT resolution) to 8.1 min (93 cm3 at 1.1 × 1.1 × 1.0 mm3), at 2%
uncertainty for Precision MC for the 7 examined lung cases and 4–6 h for IDC, which, however, is not optimized for
efficiency but used as a gold standard for accuracy.
Conclusions: Both accuracy and efficiency of Precision MC in the context of MLC based planning for the
CyberKnife M6 system were benchmarked against MC based IDC framework. Precision MC is used in clinical
practice at our institute.
Keywords: CyberKnife, Monte Carlo, Benchmarking, Dose calculation, TPS, QA
Introduction
The implementation of stereotactic radiosurgery (SRS),
stereotactic radiotherapy (SRT), and stereotactic body
radiotherapy (SBRT) has always been associated with
high demands on dosimetry for the accurate and safe
delivery of the corresponding treatments [1–3].
The Monte Carlo (MC) method plays a key role exploit-
ing the statistical nature of the photons’ and their secondary
particles’ interactions. It is generally considered as golden
standard for the fundamental investigation of particle
interaction processes, relevant for both measurement and
calculation of dose distributions. As an example, the MC
method is effectively used to determine measurement based
correction factors, which are crucial especially in small field
dosimetry [4–6].
One of the drawbacks of MC based solutions is the fact
that MC methods are very computationally expensive.
Depending on parameters like the intended statistical
uncertainty, size of the problem (i.e. voxel size, calculation
volume, etc.), it might be necessary to spend hours for the
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computation of MC based dose distributions, affecting the
clinical transferability of MC methods. However, our
group developed several strategies to overcome this limita-
tion without making unacceptable compromises in terms
of accuracy [7–10]. With respect to stereotactic treat-
ments, we recently developed a vendor independent dose
calculation (IDC) framework for the calculation of dose
distributions for the CyberKnife® M6 radiosurgery system
(Accuray Inc., Sunnyvale, CA) equipped with the InCise™
multileaf collimator (MLC) [11]. The IDC framework has
been validated against measurements and showed only
small differences in the order of 2% dose difference
or 2 mm distance to agreement between calculated and
measured dose distributions. As a consequence, the IDC
framework serves not only as a highly accurate method
for dose calculation, but is also useful for verification pur-
poses. It may be possible to reduce the clinical workload
for patient specific quality assurance (QA) by replacing
cumbersome measurements with IDC.
More recently, a new MC based dose calculation
method was released by Accuray as part of the TPS for
stereotactic treatment planning purposes using the
CyberKnife M6 equipped with the InCise MLC. While
MC based dose calculation has been available for Cyber-
Knife treatments using Cone and Iris collimators for
several years [12, 13] and is well validated [14–16], no
such validation exists for the newly introduced MC
algorithm for MLC treatments. In the following, we refer
to this implementation as Precision MC. The aim of this
work is to benchmark this commercially available dose
calculation algorithm by comparing Precision MC calcu-
lated dose distributions and resulting dose volume histo-
gram (DVH) based parameters with the corresponding
results using the IDC framework. For this purpose, the
accuracy, efficiency, and usability of Precision MC are
examined in academic and clinically motivated situations.
Material and methods
Precision MC
In our institute, the Precision MC was installed in
November 2017 and after commissioning and valid-
ation it was clinically introduced for patient treatments
[17]. For this purpose, during the commissioning phase,
the Precision MC source model parameters were
adjusted such that calculated output factors (OF), dose
profiles and tissue-phantom ratio (TPR) curves match
to the corresponding measurements.
The Precision MC dose calculation algorithm is de-
scribed by Ma et al. [12] with implementation details
information given by Heidorn et al. [18] and only a brief
summary is provided here. A measurement based virtual
source model is used to sample photons generated in the
treatment head. A single virtual source, consistent with
the linac target, is included, and its properties (energy
spectrum, source point distribution, and direction distri-
bution) are commissioned by comparison of measured
and calculated TPR, dose profile, and OF. A CT based pa-
tient model is derived by determining a mass density and
material type at each voxel. Mass density is assigned from
a user defined Hounsfield unit (HU) to mass density
calibration curve. Material type is assigned based on mass
density to be either air, soft tissue, or bone. Material type
is only used for photon interaction calculations. During
dose calculation, each photon sampled from the source
model is transported through the CT based patient model.
Photon interactions are calculated using material type and
mass density. At each interaction site a pre-simulated
particle track (containing the details of all subsequent in-
teractions and energy loss) is selected at the appropriate
energy, aligned with the photon track and overlaid onto
the patient model. Energy deposition is calculated using
the pre-generated steps in this track, scaled by local mass
density. These pre-simulated tracks are generated in a uni-
form water phantom and provided as a data library with
Precision MC. This track repeating method, together with
other variance reduction methods such as Russian
Roulette, photon splitting, and forced photon interaction
enables an efficient MC-based handling of the transport of
charged particles and leads to reduced simulation times
when compared to full MC simulations. Table 1 provides
details about the CT conversion and interaction handling
in Precision MC. In this study, Precision version 1.1.1 was
used for all calculations. This was running on a Dell
T7910 with 2 × 2.40GHz CPU and 64 GB RAM.
IDC
The IDC framework has been described in [11] and is
used in this work for benchmarking the Precision MC
Table 1 CT to voxel mass density and material type conversion for photons, electrons and positrons in both Precision MC and IDC
CT data
conversion
Precision MC IDC
Voxel mass density Voxel material type Voxel mass density Voxel material type
Particle type
Photons
(primary and
secondary)
User defined CT-HU to
mass density calibration
curve, identical to IDC
Mass density to material type.
Material is either air, soft tissue,
or bone
User defined CT-HU to mass
density calibration curve, identical
to Precision MC
CT material calibration
curve based on
Vanderstraeten et al 2017
Electrons and
Positrons
As above Water As above As above
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algorithm. For this purpose, the IDC was commissioned
based on measured OFs, dose profiles and depth dose
data from the same CyberKnife M6 system. It is import-
ant to note that the IDC framework was not intended to
work as a clinical tool for treatment planning but was
developed in order to serve either as a patient specific
QA tool or to serve as a benchmark tool (as in this
study). Also for the IDC, EGSnrc served as a basis but in
contrast to Precision MC, the IDC framework simulates
all particles within a specific material according to the
methods described in [11]. By this means, there is no
pre-simulation applied resulting in computation times,
which are expected to be longer than those of Precision
MC. More details about the IDC implemented method is
given in Table 1. All MC transport parameters remained
identical to [11] with a global photon cut energy of 10 keV
and 700 keV for electrons. Bremsstrahlung cross-sections
were Bethe-Heitler and photon cross sectional data were
read from the XCOM library.
Benchmarking
In order to benchmark the accuracy and general per-
formance of Precision MC, cases were either created
artificially or originated from clinical routine (i.e. were
clinical cases previously treated with CyberKnife using
fixed size cone or Iris collimators and now re-planned
using MLC and Precision MC). Starting with simplified
situations (academic cases), complexity is increased to
treatment plans applied to phantoms (phantom cases)
and finally to clinical cases as detailed below.
The benchmark consists of the comparison of the
calculated dose distribution of Precision MC and the
corresponding dose distribution as either calculated by
IDC or measured on the CyberKnife M6 system.
Academic cases
The basic setup for the benchmarking study is similar to
the setup used to commission the IDC system [11], but
now compared to matching calculations from Precision
MC. A homogeneous water tank with a size of 201 ×
201 × 200 mm3 is used. Within this water tank OFs, dose
profiles, and depth dose curves are measured by a PTW
60019 microDiamond (PTW-Freiburg GmbH, Freiburg,
Germany) detector or calculated using IDC and Precision
MC. For this purpose, rectangular fields were shaped by
the Incise MLC and different field sizes ranging from
7.6 mm × 7.7 mm to 115.0 mm × 100.1 mm were investi-
gated. These dose quantities have already been used for
the commissioning of both the IDC [11] and Precision
MC models. It should be noted, however, that this
measured dataset is similar, but not identical. First of
all a different detector was used for the commissioning:
Specifically, during commissioning, the dose profiles,
the TPR’s at all field sizes, and OF’s at the smallest field
size were measured using a SFD diode detector (IBA
Dosimetry GmbH, Schwarzenbruck, Germany) instead
of the microDiamond. No corrections were applied to
the OF measured using either detector. Moreover, TPR
data were used for the commissioning of the Precision
MC model, while PDD data was used for IDC commis-
sioning as well as the benchmarking study. Therefore,
the simple academic test described here allows not only
to validate the dose calculation accuracy but also the
quality of the commissioning itself. As a first step,
commissioning quality is assessed. Based upon this,
data from 3D dose distributions is compared to mea-
surements. Only then can data from Precision MC be
benchmarked against IDC. These steps are illustrated
in Fig. 1 for the example of OFs.
The first step is assessing the quality of the
commissioning by comparing OFs from Precision MC
beam data tables (originating from the commissioning
process itself and thus only available in Precision
MC) to measurements. Building upon this, OFs, dose
profiles at 15 mm depth and depth dose curves are
extracted from 3D dose distributions and compared
to measurements. The third step then compares OFs,
dose profiles and depth dose curves from 3D dose
distributions between IDC and Precision MC. While
IDC commissioning results have been presented pre-
viously for SFD measurements [11], this work updates
results with microDiamond measurements. All dose
Fig. 1 Schematic diagram describing the benchmarking of Precision MC in three steps. Blue arrows show the examined concepts and bullet
points give the example of benchmarking OFs. Apart from OFs, step 2 and 3 were performed for dose profiles in 15mm depth and depth
dose curves
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profiles, depth dose curves and OFs are measured
and calculated with a source-to-surface distance (SSD)
of 785 mm. Calculation in the homogeneous water
tank is performed using a voxel size of 1 × 1 × 1 mm3.
Phantom cases
For benchmarking purposes of a dose calculation algo-
rithm, it is important to investigate the impact of inho-
mogeneities [19]. In radiation therapy, this is typically
accomplished using phantoms such as lung or pelvis
phantoms. In this study, one lung and two prostate
treatment plans were generated on a thorax and a male
pelvis phantom, respectively (CIRS IMRT thorax / CIRS
IMRT pelvic 3D phantom, CIRS, Inc., Norfolk, VA).
Besides the thorax phantom plan, all treatment plans
were generated using sequential optimization and
Table 2 summarizes treatment plan characteristics of
these cases.
The thorax phantom is outfitted with a 20 mm diam-
eter soft tissue equivalent spherical volume represent-
ing a tumor. A simplified treatment plan referred to as
case 1 is generated, containing a single MLC shaped
beam conformed to the tumor volume insert. For this
case a single dose of 46 Gy to the 80% isodose line was
prescribed and corresponding dose distributions were
calculated by Precision MC, IDC and, additionally for
illustration purposes, the finite size pencil beam (FSPB)
algorithm implemented in Precision (the lateral kernel
scaling option was not used).
For the first prostate treatment plan (case 2), a dose
of 33.13 Gy was prescribed to the 80% isodose line.
Sequential optimization was used to create a treatment
plan with 47 beams and 151 segments. To avoid calcula-
tion uncertainties in small fields, a subset of this treatment
plan was created (case 3) by manually erasing small MLC
apertures (so called “perimeter shapes”, which can be
enabled during optimization to fill possible underdosage
at the edge of the PTV). This subset retained 26 beams
and 84 segments. The number of MU of the remaining
beams was unaltered, resulting in a prescribed dose of
32.58 Gy.
Clinical cases
In order to investigate the difference between Precision
MC and IDC, clinical cases were used and dose distri-
butions were recalculated by both algorithms. By this
means, dose distributions of 7 lung treatment plans
were calculated using Precision MC as well as IDC. A
dose prescription of 50 Gy by 5 fractions or 60 Gy by 3
fractions to the 74–79% isodose lines was used.
Depending on the case, this results in 19–24 beams and
31–58 segments.
Calculation details
Dose distributions calculated in Precision MC targeted a
statistical uncertainty of 1% for phantom and 2% for
lung cases after smoothing, and were calculated at the
native CT voxel resolution (i.e. as shown in the CT voxel
size column of Table 2). Dose distributions from Preci-
sion MC are smoothed with a Gaussian kernel. IDC dose
calculations were also performed with the calculation
volume and voxel size equaling the 3D CT data set. IDC
dose distributions were calculated to mean statistical
uncertainties of < 1.9% in voxels receiving 50% of the
respective dose maximum for all cases. For analysis, the
resolution of each dose distribution (Both Precision MC
and IDC) was reduced by a factor of two along any axis
with a voxel edge length of < 1.5 mm. Analysis was then
performed with the voxel size given in Table 2 under
“averaged voxel size”.
Analysis
Resulting dose distributions were benchmarked by ana-
lyzing dose differences, DVHs and by performing 3D
gamma evaluation [20]. In all DVHs, the dose axis
Table 2 Treatment plan characteristics
Case Tumor site PTV size [cc] CT voxel size
[mm]
Averaged voxel size
(used for analysis) [mm]
Beams MLC segments Prescribed
dose [Gy]
Prescription
isodose [%]
1 Lung phantom 9 0.711 × 0.711 × 0.625 1.42 × 1.42 × 1.25 1 1 46.08 80
2 Prostate phantom 47 0.633 × 0.633 × 0.625 1.27 × 1.27 × 1.25 47 151 33.13 80
3 Prostate phantom 47 0.633 × 0.633 × 0.625 1.27 × 1.27 × 1.25 26 82 32.58 80
4 Lung 83 0.977 × 0.977 × 1.250 1.95 × 1.95 × 2.50 21 56 50.5 76
5 Lung 93 1.089 × 1.089 × 1.0 2.18 × 2.18 × 2.00 23 58 50.0 75
6 Lung 39 0.977 × 0.977 × 2.50 1.95 × 1.95 × 2.5 24 52 50.0 74
7 Lung 19 1.172 × 1.172 × 1.50 2.34 × 2.34 × 1.5 19 37 50.0 75
8 Lung 22 1.086 × 1.086 × 1.250 2.17 × 2.17 × 2.50 22 53 60.0 76
9 Lung 21 0.859 × 0.859 × 1.0 1.72 × 1.72 × 2.00 21 31 50.0 73
10 Lung 24 0.824 × 0.824 × 1.50 1.65 × 1.65 × 1.50 24 48 50.76 79
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represents dose relative to the Precision MC dose max-
imum (100%) and volume relate to the volume of each
contoured structure. Gamma evaluation was performed
with 2% dose difference (global, relative to Precision MC
dose maximum), 1 mm distance to agreement criteria
and a global 10% dose threshold and IDC calculated
dose was set as reference for gamma evaluation. Further-
more, mean dose to the PTV and relative lung volume
receiving 20 Gy or more (lung V20) were compared be-
tween Precision MC and IDC. To analyze efficiency, cal-
culation times for the 7 clinical lung cases were
recorded in Precision MC.
Results
Academic cases
The commissioning process resulted in optimized virtual
source model parameters for Precision MC, which are
6.3MeV for the kinetic energy and 2.5 mm FWHM
Gaussian intensity distribution of the primary electron
beam. Within Precision MC, calculated OFs are saved in
corresponding tables of the commissioning workspace.
The comparison between these initial OFs from the
commissioning and the corresponding measured OFs
reveals an agreement within ±0.2%, indicating good
quality of the Precision MC commissioning. This also
reflects the best agreement, which can be realized in any
of the upcoming experiments, since it actually describes
the quality of the commissioning itself.
Investigating OFs calculated by manually setting up a
treatment plan with a single beam incident on a water
phantom at 785 mm SSD for a full 3D water tank, and
extracting them from calculated dose distributions
shows an agreement within ±1.7% between both IDC
and measurement (Table 3, column 4) and between
Precision MC and IDC (Table 3, column 5), except for
the smallest field size. For the smallest field size, the
disagreement of the OF by Precision MC with
measurements is − 1.9%, while IDC determines the OF
to be 2.5% lower than Precision MC. Table 3 details the
comparison between OFs calculated using Precision MC,
IDC, and measurement.
Figure 2 shows dose profiles in 15mm depth along leaf
travel direction (Fig. 2a) and depth dose curves (Fig. 2b)
in a homogeneous water tank for microDiamond mea-
surements, Precision MC and IDC. For better clarity,
the plots only display selected results from the smallest
(7.6mm× 7.7mm), an intermediate (46.2 mm× 46.2mm)
and the largest (115.0mm× 100.1mm) rectangular MLC
fields. Dose profiles at a depth of 15mm in water show an
agreement within ±3.1% or 1mm between Precision MC
and IDC for all 11 analyzed field sizes with select sizes
shown in Fig. 2a. The largest discrepancy was found in the
dose profile shoulder region of the two largest of all
assessed field sizes, where Precision MC calculates higher
doses than IDC. Between Precision MC and measure-
ments, dose profiles agreed within ±2.2% or 1mm.
In Fig. 2b, depth dose curves are shown. Depth dose
curves agree within ±2.3% or 1mm over all 11 assessed
field sizes between Precision MC and IDC, and the largest
difference is observed for the smallest MLC field size
(7.6 mm × 7.7 mm), where the IDC framework calcu-
lates lower doses than measurement and Precision MC.
Between Precision MC and measurement, depth dose
curves also agree within 2.3% or 1 mm for all assessed
field sizes.
Phantom cases
The first phantom case considered demonstrates the
impact of the MC based dose calculation method, when
compared with Precision FSPB. As can be seen from Fig. 3,
for a single beam incident on a lung case, the FSPB algo-
rithm results in a 9.3% overestimation of the mean PTV
dose when compared with IDC or Precision MC. The
comparison between IDC and Precision FSPB also reveals
Table 3 Output Factors. Column 2 shows commissioning quality as the Precision MC commissioning process fit OFs to measured
Field Size [mm] (Commissioning fit -
measured) / measured [%]
(Precision MC - measured) /
measured [%]
(IDC – measured) /
measured [%]
(Precision MC - IDC) /
IDC [%]
7.6 × 7.7 0.1 − 1.9 −4.3 2.5
15.4 × 15.4 − 0.1 − 1.4 − 1.1 − 0.3
23.0 × 23.1 −0.1 −1.0 − 0.5 −0.5
30.8 × 30.8 −0.1 −1.2 − 0.1 − 1.0
38.4 × 38.4 0.1 −1.0 0.0 −1.0
46.2 × 46.2 0.0 −1.2 −0.3 − 0.9
53.8 × 53.9 0.0 −2.0 −0.2 −1.7
69.2 × 69.3 0.1 −1.2 −0.5 − 0.6
84.6 × 84.7 0.2 0.5 −0.2 0.7
100.0 × 100.1 0.1 − 0.8 −0.2 − 0.7
115.0 × 100.1 0.0 0.2 −0.3 0.4
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small dose differences at the phantom boundaries to air
and large differences (> 25%) in lung equivalent material
inside the phantom (Fig. 3d).
For the two prostate phantom cases, comparative re-
sults between Precision MC and IDC are given in Fig. 4
(Only case 2 is shown for brevity, as it includes all MLC
apertures while case 3 is a subset). While the gamma
passing rates (99.9% for both cases) demonstrate gen-
erally an excellent agreement between the two
methods, IDC shows slightly lower PTV mean doses
Fig. 2 Dose profiles (a) along MLC leaf travel direction and depth dose curves (b) for microDiamond measurements (solid), Precision MC (dashed)
and IDC (symbols) for 7.6 mm× 7.7 mm (blue), 46.2 mm × 46.2 mm (green) and 115.0 mm× 100.1 mm (red) rectangular MLC fields in water
Fig. 3 Transversal dose distributions of the single (approximately 20 mm diameter) beam lung case as calculated by (a) the Precision FSPB
algorithm (b) Precision MC (c) IDC, respectively and resulting dose differences for (d) and (e) (IDC – Precision FSPB) / Dmax (Precision FSPB) and
(f) (IDC – Precision MC) / Dmax (Precision MC). Note the different scales for (d, e and f)
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(− 1.0% and − 0.8%, for case 2 and 3, respectively) as
compared to Precision MC.
Clinical cases
Due to the nature of this work to benchmark the Precision
MC for clinical cases, different lung cases were investi-
gated because it is expected that they are the most
challenging cases with regard to accuracy of the dose
calculation task. Table 4 shows results of dosimetric com-
parisons for all phantom and clinical cases. For the clinical
lung cancer cases (cases 4–10), mean PTV doses agree
within − 1.0 to 2.3%.
As an example, case 6 is considered in Fig. 5, where
the isodose lines (a), the gamma distribution (b), and the
Fig. 4 a Transversal slice with isodose plot, b gamma distribution, and c DVH for the prostate phantom case containing all MLC apertures (case
2). Precision MC solid, IDC dashed
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DVH plots (c) are shown. In this case, mean PTV doses
agree perfectly between Precision MC and IDC (best-
case example).
As a worst-case example, case 7 is considered in Fig. 6.
For this case, PTV mean dose differs the most among all
considered cases, as it is 2.3% higher for IDC compared
to Precision MC.
In general, as can be seen from the previous figures,
voxels failing gamma evaluation are primarily located at
interfaces of tissues of different densities. On the other
hand, lung V20 agrees between IDC and Precision MC
within ±1.5% difference and gamma passing rates when
comparing IDC to Precision MC are 98.1% or higher for
all cases (as shown in Table 4). Calculation times for the
seven clinical lung cases in Precision MC at native CT
resolution and 2% requested uncertainty ranged between
2min 11 s (case 6) and 8min 7 s (case 5). If the axial
plane resolution was reduced by a factor of two (offered
in Precision MC as a “medium” resolution option) these
reduced to 41 s and 2min 11 s, respectively.
Discussion
In this work, a commercially available dose calculation
algorithm (Precision MC) for CyberKnife M6 treatments
was benchmarked against measurements as well as against
an independent dose calculation framework (IDC). A prior
benchmarking study of the Precision MC for MLC
included single beam tests in which Precision MC and
FSPB calculations were compared to film and chamber
measurements in a heterogeneous slab phantom [18].
That study showed good agreement (2%/1mm 2D gamma
passing rates of 91.2 ± 1.5%) between Precision MC and
measurement in very low density lung substitute materials
with localized anomalies due to a simplification in
electron transport, which improved further after a
modification was made to the electron transport algorithm
(gamma passing rates of 96.6 ± 1.2%). That modification
was introduced by the manufacturer before work for the
current study started and is included in the Precision MC
version used in our study. The work concentrated on
MLC only, since MC-based methods are already existing
for the other two collimator options (i.e. fixed size cones,
IRIS) for the CyberKnife system. For this benchmark,
different complexity levels were considered by looking at
simple cases such as a homogeneous water tank, phantom
cases reflecting lung or pelvis treatments, and clinical
cases (all lung). By this means, it was possible to compre-
hensively investigate an entire spectrum of situations,
which are not only of physics interest but also of clinical
relevance.
Generally, for the cases considered, there is good
agreement between Precision MC, IDC, and measure-
ments. This was quantified by dose difference, distance
to agreement, gamma evaluation, and DVH analyses
(Tables 3 and 4).
The work also indicates the difficulty of accurately
handling small fields in radiation therapy. Although IDC
is based on the MC method – generally known as the
most accurate dose calculation method – we observed
dosimetric differences between IDC and measurements
in the order of 4% for the smallest field. Since for the
clinical cases, the treatment plans also include small
fields, the observed differences for the clinical cases can
partly be associated to this effect. Part of these differ-
ences can also be attributed to effects of partial source
obscuration in the IDC MC model for the smallest field.
While for two prostate phantom treatment plans and
seven clinical (lung) treatment plans the gamma evalu-
ation between Precision MC and IDC results in passing
rates > = 98.1%, we also showed the relevance of using
Table 4 Comparison of VOI doses and gamma passing rates for all ten cases (Case 1–3 are phantom cases, 4–10 are clinical cases).
Gamma analysis performed using 2% (global) / 1 mm criteria with a 10% dose threshold
Case
number
PTV mean
dose IDC [Gy]
PTV mean dose
Precision MC [Gy]
PTV mean dose change
(IDC – Precision MC) /
Precision MC [%]
Lung
V20 IDC [%]
Lung V20
Precision MC [%]
Lung V20 change
(IDC – Precision MC) /
Precision MC [%]
Gamma
passing rate [%]
1 39.1 39.1 0.0 96.2
1 FSPB 43.1 −9.3 36.2
2 36.8 37.1 −0.8 99.9
3 38.3 38.7 −1.0 99.9
4 56.4 55.6 1.4 11.9 11.7 1.5 99.6
5 54.0 54.2 −0.4 7.5 7.7 −1.5 98.1
6 58.7 58.7 0.0 2.9 2.9 0.0 99.7
7 56.4 55.1 2.3 1.0 1.0 0.0 99.4
8 66.9 67.6 −1.0 2.3 2.3 0.9 98.2
9 55.7 55.5 0.4 6.7 6.7 0.3 99.0
10 56.2 55.7 0.9 1.1 1.1 0.0 99.6
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MC instead of FSPB for heterogeneous anatomical situa-
tions. The addition of MC based dose calculation to
MLC based CyberKnife treatments was thus important
for treatments in regions such as lung, liver and medias-
tinal tumors.
Nevertheless, even though both algorithms – Precision
MC and IDC – are based on the MC method, residual
differences in the calculated dose distributions remain,
which cannot be explained by statistical uncertainty
only. Besides the different beam models used, the
underlying MC transport methods differ (proprietary
code and EGSnrc, respectively) and thus serve as an ex-
planation for the observed differences. Moreover, as out-
lined in this work, both material conversion and electron
track generation is handled differently in the two algo-
rithms. Material conversion for photon interaction simu-
lation on one hand, is simplified in Precision MC,
assigning one of three materials (air, soft tissue or bone)
to voxels instead of the 14 stoichiometric material com-
positions used in IDC. For electrons, on the other hand,
Fig. 5 a Transversal slice with isodose plot, b gamma distribution, and c DVH for the clinical case 6 (lowest PTV mean dose change, “best-case”).
Precision MC solid, IDC dashed
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interactions are pre-simulated in water. This leads to
dose differences near inhomogeneous tissue (air/soft tis-
sue/bone interfaces), which consequently are then ob-
served in the corresponding phantom and clinical cases.
As shown in Figs. 5b and 6b, Gamma values peak in re-
gions of tissue interfaces (e.g. bronchi, pleura or the sur-
face of the vertebral body) with IDC showing lower dose
than Precision MC in air close to soft tissue and higher
dose in soft tissue close to bone. These dose differences
appear to be confined to small regions, suggesting the
electron pre-simulation in water being the underlying
cause. Even though peak differences in the dose of 2.5%
were observed, these are generally acceptable differences
for clinical routine work with gamma passing rates for
2% / 1 mm of 98.1% or greater [1].
Calculation efficiency of Precision MC is optimized
(whereas in IDC it is deliberately not) and compares
favorably to similar described frameworks [21]. This is
to be expected, as IDC serves a “gold standard” purpose,
not employing any efficiency improving approximations.
Fig. 6 a Transversal slice with isodose plot, b gamma distribution, and c DVH for the clinical case 7 (highest PTV mean dose change, “worst-
case”). Precision MC solid, IDC dashed
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While IDC takes 4–6 h to calculate dose to clinically
acceptable mean statistical uncertainties of about 2%
[11], Precision MC does so within 2.2–8.1 min at native
CT resolution (note that if the resolution is reduced
to 256 × 256 x number of slices, these times reduce to
41–132 s).
Both accuracy and efficiency of the Precision MC dose
calculation are within clinically accepted limits rendering
the system practical for routine use.
Conclusions
Precision MC dose calculation for MLC based CyberKnife
treatments was successfully benchmarked against IDC
and measurements. Dose differences of Precision MC to
gold standard IDC are sufficiently small for clinical use
with greatly improved efficiency.
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